share_log

NAVA HEALTH MD, LLC (NAVA) Announces December 16th IPO

NAVA HEALTH MD, LLC (NAVA) Announces December 16th IPO

納瓦健康醫學有限責任公司(NAVA)宣布 12 月 16 日首次公開招股
Defense World ·  2022/12/08 01:22

NAVA HEALTH MD, LLC (NAVA) is planning to raise $18 million in an initial public offering (IPO) on Friday, December 16th, IPO Scoop reports. The company will be issuing 3,000,000 shares at a price of $5.00-$7.00 per share.

據IPO Scoop報道,Nava Health MD,LLC(Nava)計劃在12月16日(星期五)進行首次公開募股(IPO),籌集1800萬美元。該公司將以每股5.00美元至7.00美元的價格發行300萬股。

In the last 12 months, NAVA HEALTH MD, LLC generated $9.3 million in revenue and $80,000 in net income. NAVA HEALTH MD, LLC has a market-cap of $87 million.

在過去12個月中,Nava Health MD,LLC創造了930萬美元的收入和8萬美元的淨收入。Nava Health MD,LLC的市值為8700萬美元。

WestPark Capital served as the underwriter for the IPO.

Westpark Capital擔任此次IPO的承銷商。

NAVA HEALTH MD, LLC provided the following description of their company for its IPO: " Nava is a vertically integrated tech-enabled healthcare practice combining traditional, functional, holistic and regenerative medicine. (Incorporated in Delaware) Our innovative medical practice uses a data-driven personalized approach to optimize health and increase longevity. We provide each client with an individualized wellness roadmap tailored to their specific symptoms, medical needs and personal goals, which we refer to as their "Custom Vitality Plan" or "CVP." The client's CVP is developed as part of our proprietary diagnostic process, the "Nava Method," which utilizes propriety software owned and developed by Nava. We believe Nava's proprietary diagnostic process enables our practitioners to leverage various synergistic products and services for our clients. We deliver our health services through three (3) physical locations in the Baltimore/Washington Metro region. We currently plan to open up to eight (8) additional locations by the end of 2023, subject to market conditions and anticipated demand for our services. Our on-premises locations offer a premium client experience and luxurious spa-like atmosphere. Our on-premises locations provide hands-on treatment options, including, but not limited to, physician appointments and medical procedures, intravenous (IV) micronutrient therapies, massage, acupuncture and our aesthetic services such as Botox injections and body sculpting. We also provide services through telehealth, delivering on-demand healthcare via mobile devices, video or phone in Alabama, Arizona, Colorado, Delaware, Illinois, Maryland, Michigan, Minnesota, New York, Pennsylvania, Tennessee, Texas, Vermont, Virginia, Washington, D.C., and Wisconsin. Nava Medical specializes in bio-identical hormone optimization, medically supervised weight loss programs, Platelet Rich Plasma (PRP) procedures, digestive health programs, advanced diagnostic testing, IV micro-nutrient therapy, hyperbaric oxygen therapy, light therapy, intelligent bioenergetics therapy, B-12 injections, Botox injections, dermal fillers, body sculpting and a full line of premium grade nutraceuticals, supplements and skin health/ aesthetic products. Nava Medical also has a fully equipped in-office clinical laboratory that provides diagnostic testing for Nava's client, conveniently increasing the speed of research and results. Lab tests include, but are not limited to, chemistry, hematology, immunoassay, genetic, allergy, food sensitivity and other blood and urine panels. Nava has six general areas of expertise and offerings, including but not limited to Diagnostic Testing, Bio-identical Hormone Replacement Therapies (BHRT), Regenerative Therapies, Aesthetics, Functional Nutrition and premium-grade retail products. **Note: Revenue and net income figures are for the 12 months that ended June 30, 2022. (Note: Nava Health MD, LLC filed an S-1/A on Dec. 5, 2022, in which its increased the size of its IPO by adding a secondary portion – 1.02 million shares (1,022,521 shares) to be offered by the selling stockholders – to the deal's initial size of 2.0 million shares being offered by the company. The price range remained at $5.00 to $7.00. The IPO is now expected to raise a total of $18.12, but the company will still receive only $12.0 million in IPO proceeds. The company will not receive any proceeds from the sale of the selling stockholders' shares. Nava Health MD, LLC filed its S-1 on Oct. 27, 2022, and disclosed terms for its IPO – 2.0 million shares at $5.00 to $7.00 to raise $12.0 million. The company submitted confidential IPO documents on Sept. 13, 2022.) ".

Nava Health MD,LLC在其首次公開募股(IPO)中提供了以下對他們公司的描述:“Nava是一家垂直整合的技術支持的醫療實踐,結合了傳統、功能、整體和再生醫學。(在特拉華州成立)我們的創新醫療實踐使用數據驅動的個性化方法來優化健康和延長壽命。我們為每位客戶提供根據他們的特定癥狀、醫療需求和個人目標量身定做的個性化健康路線圖,我們將其稱為“定製活力計劃”或“CVP”。客戶的CVP是作為我們專有的診斷過程“NAVA方法”的一部分開發的,該方法利用了NAVA擁有和開發的專有軟體。我們相信,Nava的專有診斷流程使我們的從業者能夠為我們的客戶利用各種協同產品和服務。我們通過巴爾的莫耳/華盛頓大都會地區的三(3)個實體地點提供醫療服務。我們目前計劃根據市場條件和對我們服務的預期需求,在2023年底之前再開設多達八(8)家門店。我們酒店內的位置提供優質的客戶體驗和奢華的水療氛圍。我們酒店內的位置提供現場治療選項,包括但不限於預約醫生和醫療程式、靜脈注射(IV)微量營養素療法、按莫耳、針灸和我們的美容服務,如肉毒桿菌注射和身體塑形。我們還通過遠端醫療提供服務,通過移動設備、視頻或電話在阿拉巴馬州、亞利桑那州、科羅拉多州、特拉華州、伊利諾伊州、馬利蘭州、密歇根州、明尼秀克達州、紐約、賓夕法尼亞州、田納西州、德克薩斯州、佛蒙特州、弗吉尼亞州、華盛頓特區和威斯康星州提供按需醫療服務。Nava Medical專注於生物相同的激素優化、醫學監督的減肥計劃、富血小板血漿(PRP)程式、消化健康計劃、高級診斷測試、IV微營養療法、高壓氧療法、光療法、智慧生物能量療法、B-12注射、肉毒桿菌注射、皮膚填充物、身體塑造和全系列優質營養食品、補充劑和皮膚健康/美容產品。Nava Medical還擁有設備齊全的辦公室臨床實驗室,為Nava的客戶提供診斷測試,從而方便地提高研究和結果的速度。實驗室檢測包括但不限於化學、血液學、免疫分析、遺傳、過敏、食物敏感性和其他血液和尿液檢查。NAVA擁有六個一般領域的專業知識和產品,包括但不限於診斷測試、生物相同的激素替代療法(BHRT)、再生療法、美學、功能營養和優質零售產品。*注:收入和淨收入數位是截至2022年6月30日的12個月的數據。(注:Nava Health MD,LLC於2022年12月5日提交了S-1/A檔案,其中增加了第二部分-將由出售股東發行的102萬股(1022,521股)-在該公司發行的200萬股的初始規模基礎上增加了第二部分。價格區間保持在5美元至7美元之間。目前預計此次IPO總共將籌集1812美元,但該公司仍將只獲得1200萬美元的IPO募集資金。該公司將不會從出售股東股份中獲得任何收益。Nava Health MD,LLC於2022年10月27日提交了S-1檔案,並披露了其IPO-200萬股票的條款,價格在5美元至7美元之間,以籌集1,200萬美元。該公司於9月9日提交了保密的IPO檔案。2022年13號。)“。

NAVA HEALTH MD, LLC was founded in 2013 and has 90 employees. The company is located at 9755 Patuxent Woods Drive Suite 100 Columbia, MD 21046 and can be reached via phone at (410) 910-6156 or on the web at

Nava Health MD,LLC成立於2013年,擁有90名員工。該公司位於馬利蘭州21046哥倫比亞市Patuxent Wood Drive Suite 100號郵編:9755,可通過電話(4109106156)或通過以下網址聯繫:

Receive News & Ratings for NAVA HEALTH MD LLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NAVA HEALTH MD LLC and related companies with MarketBeat.com's FREE daily email newsletter.

接受Nava Health MD LLC Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Nava Health MD LLC和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論